Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Therapeutic Proteins to 2016: Drugs, Devices, Diseases, Markets and Forecasts

March 22, 2013

DUBLIN, March 22, 2013 /PRNewswire/ –

Research and Markets [http://www.researchandmarkets.com/research/n4sgxh/therapeutic ]
has announced the addition of the “Therapeutic Proteins to 2016. Drugs, Devices, Diseases,
Markets and Forecasts” [http://www.researchandmarkets.com/research/n4sgxh/therapeutic ]
report to their offering.

(Logo:
http://photos.prnewswire.com/prnh/20130307/600769 )

In recent years, the number of protein-based pharmaceuticals reaching the marketplace
has increased exponentially. The clinical application of these drugs is limited by a lack
of desirable attributes for adequate absorption or distribution.

It therefore becomes critical to formulate these drugs into safe, stable and
efficacious delivery systems. Because these drugs face formidable enzymatic and
penetration barriers when administered orally, peptide and protein drugs continue to be
developed almost exclusively for parenteral administration.

These combination drug-device products, where the drug and device are clinically
tested and approved as a single product entity, are becoming one of the fastest new drug
categories. The growth of protein drug products is having a significant effect on the way
drugs and devices are developed.

Cooperation between device designers and drug developers is occurring much earlier in
the drug development cycle, allowing device designs in many cases to be tailored to the
bioavailability targets and pharmacokinetic profiles of specific drug therapies.

Highlights:

– Analyzes approved therapeutic protein products and pipeline candidates and assesses
the market potential for existing and probable future protein drug

– Examines protein delivery design issues, packaging, distribution and technology
factors

– Assesses the role of protein formulation decisions on therapeutic protein
commercialization and market potential

– Examines historical protein drug data for nine major therapeutic segments and
provides forecasts by disease segment to 2016

– Profiles therapeutic protein companies, their commercial products, product
development activity, and business strategies

Key Topics Covered:

Executive Summary

Protein Therapeutics Market Dynamics

Therapeutic Protein Commercialization – Success Factors

Protein Drugs – Drug Classes and Therapeutic Targets

Protein Drug Therapeutics – Disease Segment Analysis & Forecasts

Market and Regulatory Factors

Protein Drug Therapeutics – Company Profiles

For more information visit

http://www.researchandmarkets.com/research/n4sgxh/therapeutic

Research and Markets is the world’s leading source for international market research
reports and market data. We provide you with the latest data on international and regional
markets, key industries, the top companies, new products and the latest trends.

        Research and Markets
        Laura Wood, Senior Manager.
        press@researchandmarkets.com
        U.S. Fax: +1-646-607-1907
        Fax (outside U.S.): +1-353-1-481-1716

Sector: Pharmaceuticals
[http://www.researchandmarkets.com/categories.asp?cat_id=16&campaign_id=n4sgxh ]


    Photo: 

http://photos.prnewswire.com/prnh/20130307/600769

SOURCE Research and Markets


Source: PR Newswire